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ABSTRACT
In unicellular and multicellular eukaryotes, elaborate
gene regulatory mechanisms facilitate a broad range
of biological processes from cell division to morpho-
logicaldifferentiation.Inordertofullyunderstandthe
gene regulatory networks involved in these biologi-
cal processes, the spatial and temporal patterns of
expression of many thousands of genes will need
to be determined in real time in living organisms.
Currently available techniques are not sufficient to
achieve this goal; however, novel methods based
on magneticresonance (MR) imaging may beparticu-
larly useful for sensitive detection of gene express-
ion in opaque tissues. This report describes a novel
reporter gene system that monitors gene expression
dynamicallyandquantitatively,inyeastcells,bymea-
suring the accumulation of inorganic polyphosphate
(polyP) using MRspectroscopy(MRS)orMR spectro-
scopicimaging(MRI).Becausethissystemiscomple-
tely non-invasive and does not require exogenous
substrates, it is a powerful tool for studying gene
expression in multicellular organisms, as well.
INTRODUCTION
In situ hybridization is the most precise, currently available
method for obtaining spatial information on gene expression
at the subcellular level. However, a major drawback of this
method is that it cannot be performed in living cells or in real
time: the cells or tissues to be analyzed must be immobilized
and exposed to harsh chemicals that are incompatible with
living cells. Thus, spatial and temporal information on gene
expression cannot be measured simultaneously using in situ
hybridization technology. In recent years, several non-
invasive methods for detecting gene expression have been
developed, which do not have this limitation. These methods
use reporter genes, such as luciferase or green ﬂuorescent
protein, whose expression stimulates an optically detectable
signal (1,2). Although these methods can be used in living
cells, the optical signals on which the methods depend only
penetrate 1–2 cm of tissue; thus, internal tissues of animal or
human subjects cannot be analyzed, because the gene expres-
sion signal is obscured by light absorption and/or light scat-
tering before it can reach the signal detector (3). Radionuclide
imagingmethods suchaspositronemissiontomography(PET)
and single-photon emission tomography (SPECT) offer the
advantages of a non-invasive method and can measure gene
expression in internal tissues (3). These techniques are
well-suited for clinical use, but the spatial resolution, which
is 1–2 mm, is not sufﬁcient for research applications that
demand resolution at or below the single cell level. A second
disadvantage of these methods is that they require exposure of
the subject to radioactive isotopes, which could be undesirable
or disallowed for some applications.
MR spectroscopic imaging (MRI) is a non-invasive method
with a spatial resolution at least 10 times greater than radio-
nuclide imaging that can be used to visualize deep tissues (3).
Weissleder (4) and Meade (5) were among the ﬁrst to use
MRI-based detection with reporter genes encoding the trans-
ferrin receptor and b-galactosidase, respectively, to analyze
gene expression in cells treated with specially designed
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doi:10.1093/nar/gkl135substrates for these gene products. More recently, an MRI-
based reporter system was developed using either the heavy
subunit of ferritin or the light and heavy subunits of ferritin.
This system does not require use of a specially designed sub-
strate, but depends on the fact that ferritin is a metalloprotein
that becomes superparamagnetic when it binds endogenous
iron (6,7). This method, which was developed and applied
in mice, may be more versatile than other non-invasive
methods which require exogenous substrate. However, MRI
contrast obtained by the ferritin system is limited, since the
spin–lattice (7) or spin–spin (6,7) NMR relaxation rate of
water proton magnetizations was reported to be typically
enhanced only about a factor of two by the presence of the
iron–ferritin complex, and thus the complex serves as a nega-
tive contrast agent in T2- and T2*-weighted images. The
acquired MRI images may not be straight-forwardly inter-
preted, as the relaxation rates can be affected by other factors
and may not be suitable for fully quantitative measure of gene
expression.
Polyphosphate (polyP), a linear polymer of orthophosphate
residues linked by high-energy phosphoanhydride bonds, is
found in all organisms from bacteria to mammals (8). In
yeast, most of the cellular polyP ( 99%) is in the vacuole
where it presumably serves as both phosphate storage and a
cation chelator (8). The amount of polyP in the cell depends on
the function of the vacuolar transporter chaperone (Vtc) com-
plex (9) and the vacuolar H
+-ATPase (V-ATPase) (10). Strains
defective in either complex produce almost no detectable
polyP, but still grow normally on acidic YPD media (data
not shown) (11). These observations indicate that polyP is
dispensable for growth under normal conditions and suggest
that the polyP system could be manipulated without dele-
terious effects in living cells.
This study describes a novel MRS/MRI-based reporter
system that quantiﬁes gene expression in living cells by
measuring the accumulation of inorganic polyP. This method
does not require exogenous substrate and is suitable for
quantitative studies of gene expression in internal tissues.
In order to characterize this method, initial studies were
carried out in Saccharomyces cerevisiae, because yeast accu-
mulate polyP at a higher concentration ( 120 mM) than other
eukaryotes (8) and because yeast cells are amenable to genetic
manipulation.
MATERIALS AND METHODS
Yeast strains
Standard techniques were used for yeast growth and trans-
formation (12). The yeast strains used in this study are listed
in Supplementary Table 1. Oligonucleotide sequences used for
the strain construction are listed in Supplementary Table 2.
More detailed information is also available on request.
The YTK6337 strain was generated from BY4742
(EUROSCARF) by a fusion PCR-mediated gene replacement
method (13) using two pairs of primers, TK3950/4012 and
TK4011/3977. The strain was developed as a control strain for
studies examining the function of the TATA box binding
protein (TBP) associated factor 1 (TAF1). In the present
study, the endogenous promoter spanning up to 100 bp
upstream of the translational initiation site (A of ATG as
+1) of VTC1 of the YTK6337 strain was replaced with one
of six different promoters to generate the YTK6352, 6353,
6356, 6359, 6362 and 6365 strains by a fusion PCR-based
method. The PCR fragments used for each promoter replace-
ment were ampliﬁed by two or three pairs of primers as fol-
lows (the ampliﬁed marker gene or promoter region is shown
in parentheses): TK3755/3756 (His3MX6) + TK3757/3758
(RPS5,  593 to +139 bp, transcriptional initiation site is
+1), TK3755/3756+TK3759/3758 (RPS5,  87 to +139 bp),
TK3755/3756+TK3760/3762 (RPS5,  450 to  361 bp) +
TK3761/3758 (RPS5,  87 to +139 bp), TK3755/3756 +
TK3763/3765 (CLN2,  100 to +175 bp, transcriptional ini-
tiation site is +1), TK3755/3756+TK3760/3767 (RPS5,  450
to  361 bp)+TK3766/3765 (CLN2,  100 to +175 bp), and
TK3755/3756+TK3768/3765 (CLN2,  543 to +175 bp),
respectively. Similarly, the YTK6395, 6415 and 6489 strains
were generated from BY4742 by a PCR-based method using
primer pairs of TK3755/3756+TK4390/4391 (GAL1,  453 to
+1 bp, translational initiation site is +1), TK4985/4986
[His3MX6-GAL1 promoter ( 541 to +1 bp)-3 · HA epitope
tag] and TK4981/3756 (His3MX6) + TK4390/4982 (GAL1,
 453 to +1 bp), respectively. The YTK6397 strain was
generated from YTK6395 by a PCR-based method using
the primer pair TK4650/4651 (3 · HA epitope tag-ADH1
terminator-kanMX6).
The endogenous promoter of VMA2 in BY4741
(EUROSCARF) was replaced with the six promoters
described above to generate YTK6526, 6530, 6537, 6533,
6534 and 6527 using the following primer pairs: TK4981/
3756 + TK3757/5275 (RPS5,  593 to +139 bp), TK4981/
3756 + TK3759/5275 (RPS5,  87 to +139 bp), TK4981/
3756 + TK3760/3762 (RPS5,  450 to  361 bp) + TK3761/
5275 (RPS5,  87 to +139 bp), TK4981/3756 + TK3763/
5276 (CLN2,  100 to +175 bp), TK4981/3756 + TK3760/
3767 (RPS5,  450 to  361 bp) + TK3766/5276 (CLN2,
 100 to +175 bp) and TK4981/3756 + TK3768/5276
(CLN2,  543 to +175 bp), respectively. The PCR templates
used were pFA6a-kanMX6 (14) for TK4011/3977, pFA6a-
His3MX6 (14) for TK3755/3756 and TK4981/3756,
pFA6a-3HA-kanMX6 (14) for TK4650/4651, pFA6a-
His3MX6-PGAL1-3HA (14) for TK4985/4986 and yeast
genomic DNA for the other primers.
All gene replacements were conﬁrmed by PCR, Southern
blot and genomic DNA sequencing.
Northern blot analyses
Northern blot analyses were performed as described previ-
ously (15). To prepare the probes, DNA fragments surround-
ing the initiating methionine (VMA2 and ADH1)o r
corresponding to the entire open reading frame (VTC1)
were ampliﬁed by PCR from yeast genomic DNA, puriﬁed
and
32P-labeled by random priming.
Immunoblot analyses
Immunoblot analyses were conducted as described previously
(16). Polyclonal antibodies directed against TBP were pre-
pared as described (16). Antibodies against the HA epitope
tag (F7, mouse monoclonal) were purchased from Santa Cruz
Biotechnology, Inc. (Santa Cruz, CA).
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31P-NMR spectra were recorded on a DRX-500 spectrometer
(Bruker, Germany) equipped with a standard bore (54 mm)
11.7 T magnet.
1H-MRI and
31P-MRI were recorded on
the same spectrometer equipped with a Micro5 imaging
probehead.
For MR spectroscopy, samples were transferred into a 5 mm
NMR tube and ﬁlled with a mixture of 450 mL YPD media and
50 mL
2H2O (CIL, USA) containing 100 mg methylene diphos-
phonic acid (MDP) (Fulka, Germany), as both a concentration
and chemical shift standard. The assignments of the peaks in
the
31P-NMR spectrum were given by reference (17). The data
were acquired by applying p/2 pulses at 1 s intervals with a
sweep width of 16 181 Hz. A total of 16 384 complex points
were acquired. For each measurement 512 transients were
accumulated. Data acquisition and analysis were performed
using XWinNMR software (Bruker). The quantities of inor-
ganic polyP were estimated by the ratio of integrated peak
areas of polyP and MDP.
For MRI, samples were transferred into a 0.8 mm outer
diameter capillary glass tube (Hilgenberg, Germany). The bot-
tom of the tube was sealed with a sealing compound (Fisher,
USA). The tube was then centrifuged at 1000 r.p.m. for 3 min
to pellet the yeast cells. The tubes containing test samples and
a positional reference (water) were put into an 8 mm NMR
tube, as depicted in Figure 3A. A 3D
1H image was acquired to
deﬁne the positions of samples. Subsequently, the 2D image of
polyP in which the polyP signal was integrated longitudinally
along the axis of each capillary tube was acquired by the
∆
∆
Figure 1. TranscriptionalactivityVTC1orVMA2undercontrolofsixdifferentpromoters.GeneactivitywasdetectedbynorthernblotandinvivoMRspectroscopy
(MRS). (A) Schematic diagram of the reporter constructs used to express VTC1 or VMA2. The sequences derived from the RPS5 and CLN2 promoters are shown as
hatchedanddottedrectangles,respectively.Theregionsincludedineachconstruct(#1–6)areindicatedattheright.(B)TotalRNAwasextractedfromcellsgrowing
logarithmically at 30 C in YPD and analyzed by northern blot using a probe for VTC1 mRNA (upper panel). Transcription of VTC1 was driven by the endogenous
promoter(WT,lane1)orheterologouspromoters#1–6(lanes2–7).TheDvtc1strainwasusedasa negativecontrol(lane8)to showthatthegeneexpressionsignals
arespecifictoVTC1.TheblotwasprobedforADH1mRNAasacontrolforequalloading(lowerpanel).(C)TranscriptionofVMA2andADH1intheindicatedstrains
were measured by northern blot as described for panel (B). (D)
31P-MRS analysis of VTC1 gene expression was performed using the same strains as in panel (B).
Strain number is indicated to the left of each MRS scan. Peaks corresponding to MDP, inorganic phosphate (Pi) and inorganic polyP are marked at the top. MDP
wasaddedataknownconcentrationasachemicalshiftstandard.(E)
31P-MRSanalysisofVMA2expressionwasperformedasdescribedin(D)usingthesamestrains
as in panel (C). Strain number is indicated to the left of each MRS scan.
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the CHESS, a p/2 pulse to excite ±1500 Hz region centered at
the polyP signal with a Gaussian shaped and a non-selective
rectangular p pulse were used. The sweep width was 5000 Hz,
and TR and TE were 750 and 1.4 ms, respectively. The matrix
size was 32 · 16 (zero-ﬁlled to 64 · 32 for analysis) with the
ﬁeld of view (FOV) of 1 cm · 1 cm. For each measurement,
256 transients were accumulated. No slice selective gradient
was used. The obtained images were analyzed using
ParaVision software (Bruker).
RESULTS AND DISCUSSION
Initial studies were carried out to determine whether VTC1 and
VMA2, which encode subunits of the Vtc complex and the
Figure 2. Kinetic analysisofexpressionof VTC1and VMA2reportergenesundercontrolof theGAL1promoter.(A) Logphase yeaststrainsexpressingVTC1from
theGAL1promoterwereculturedat30 Cinraffinose-containingmediaandshiftedtogalactose-containingmediaatt¼0.Sampleswerewithdrawnattheindicated
timesandanalyzedby
31P-MRS.(B)Sampleswerepreparedasdescribedinpanel(A)usingcellsshiftedfromraffinosetogalactose(openbar,left)orfromgalactose
to glucose (hatched bar, right). PolyP was measured by
31P-MRS as shown in panel (A). The integral of the polyP peak was normalized to the MDP peak and the
percentageofthemaximumpolyPsignal(t¼24haftertheshiftfromraffinosetogalactose)wascalculated.(C)Sampleswerepreparedasdescribedinpanel(B)and
analyzedbynorthernblotwithaprobeforVTC1.TheVTC1transcriptwasnormalizedtotheADH1transcriptandthepercentageofthemaximumvalueforeachdata
was calculated. (D) Samples were prepared as described in panel (B) and used for immunoblot analysis with antibody to HA-tagged VTC1. VTC1 protein was
quantified and normalized to TATA box binding protein (TBP). Values in bar graph are the percentage of VTC1 at t ¼ 0 (lane 1). Note that the strains expressing
HA-taggedoruntaggedVTC1proteinproducedalmostthesameamountsofpolyPirrespectiveofendogenousorheterologouspromoters.(E)Sampleswereprepared
asdescribedinpanel(B)usingyeastcellsexpressingHA-taggedVMA2underthecontroloftheGAL1promoter.Northernblotanalysiswascarriedoutusingprobes
for VMA2 (upper) or ADH1 (lower). VMA2 transcript was normalized to ADH1 and the percentage of maximum VMA2 expression (t ¼ 6 h after the shift from
raffinose to galactose) was calculated. (F) PolyP was quantified by
31P-MRS in yeast cells expressing HA-tagged VMA2 under the control of the GAL1 promoter.
Samples were prepared at the indicated time after media switching as described in (B). The integral of the polyP peak was normalized to the MDP peak and the
percentage of the maximum polyP signal (t ¼ 12 h after the shift from raffinose to galactose) was calculated.
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genes with MRS detection in intact cells. This was done by
substituting six heterologous promoters of variable strength
(19) for the endogenous promoter region of chromosomal
VTC1 or VMA2 (Figure 1A). PolyP was then quantiﬁed in
yeast strains carrying the chromosomal reporter genes
with heterologous or endogenous promoters. The results
were evaluated to determine if the relationship between the
expression of VTC1 and VMA2 and the amount of polyP was
quantitative.
Yeast cells were cultured to mid-log phase in liquid YPD
mediaand divided into two aliquots. One sample was analyzed
by northern blot (Figure 1B and C) and the other was analyzed
by
31P-MRS (Figure 1D and E). The northern blot shows very
similar expression proﬁles for VTC1, VMA2 (Figure 1B and C)
and the mini-CLN2 reporter gene characterized previously
(19), suggesting that no post-transcriptional regulatory
mechanisms inﬂuence the steady-state level and/or stability
of VTC1 or VMA2 mRNA. Furthermore, the amount of mRNA
correlates well with the amount of polyP in the vacuole in all
Figure 3. Comparison of MRI, MRS and northern blot to quantify VTC1 and VMA2 reporter gene expression in yeast. (A) Schematic diagram of MRI apparatus.
A total of 16 experimental and one reference samples, loaded into 0.8 mm capillary glass tubes, were placed in an 8 mm NMR tube which was then inserted intoa n
NMRspectrometerwithanimagingprobe.(B)TheprotondensityandthepolyP-selectiveimagesweregeneratedby
1H-MRI(left)and
31P-MRI(right),respectively.
ThesamplenumberorletteranditspositioninthegridareshownbelowtheMRIdata.‘R’denotesreferenceandArabicnumeralsindicatethepromoterconstructas
described in Figure 1A. ‘W’ and ‘D’ denote wild type and Dvma2 (or Dvtc1) strains, respectively. (C) Gene expression was quantified by northern blot (open bar),
MRS(greybar)andMRI(darkgreybar).Resultsareshownasapercentageofthemaximumvalueineachdataset(asterisk).Thevaluesaretheaverageoftwo(MRI)
orthree(northernblot,MRS)independentexperimentsandshownalongwiththeSEM.(D)ThecorrelationcoefficientsbetweenthenorthernblotandMRSorMRI
datawerecalculated.DatapointsforgeneexpressiondrivenbytheendogenousVTC1orVMA2promoterswereomittedfromthecalculations,becausetheydeviated
significantly from the exogenous promoters (see text).
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In contrast, the wild-type (WT) strains accumulate more
polyP than expected based on the level VTC1/VMA2
mRNA (Figure 3C). Although the mechanism for this
enhanced accumulation is unknown, it is possible that the
endogenous VTC1/VMA2 promoters are regulated by an
uncharacterized feedback mechanism that leads to increased
production of polyP.
In order to provide an accurate measure of gene expression
in vivo, a reporter system must be temporally responsive; i.e.
it must be able to respond quickly to rapid changes in gene
expression. This aspect of the polyP system was tested
using the inducible GAL1 promoter to drive gene expression.
When the endogenous VTC1 or VMA2 promoters are replaced
with the GAL1 promoter, gene expression can be rapidly
turned on or off by changing the carbon source in the medium
from rafﬁnose to galactose or from galactose to glucose,
respectively (20). Kinetic analysis (on-rate kinetics) showed
that polyP begins to accumulate (Figure 2A) by 1–2 h after
cells are exposed to galactose and induction of VTC1 mRNA
begins (Figure 2C, left). In contrast, the level of polyP does not
decrease for at least 24 h after mRNA synthesis is suppressed
by changing carbon source (Figure 2B, right); the concentra-
tion of polyP remains high, even though VTC1 mRNA returns
to a low basal level within 1 h (Figure 2C, right) and VTC1
proteinisalsosuppressedwithin2h(Figure2D).Oneexplana-
tionforthis result isthatmay beVTC1playsaroleininitiating
vacuolar fusion (21) but does not play a direct role in synthesis
of polyP; if this is true, then induction of VTC1 would stimu-
late accumulation of polyP in the vacuole, but subsequent
suppression of VTC1 might not cause a decrease in the
level of polyP.
Similar results were observed with VMA2, in that the
amount of polyP correlated the amount of VMA2 transcript
during induction but not during repression of VMA2 mRNA
synthesis (data not shown). However, the correlation between
gene expression and polyP improved when the reporter gene
was modiﬁed with an N-terminal HA epitope tag. Thus, when
an HA-tag was fused to the amino-terminus of VMA2, a
decline in VMA2 mRNA correlated with a decline in polyP,
with a lag of a few hours (Figure 2E and F). This more rapid
response might indicate that HA-tagged VMA2 has a shorter
half-life than VMA2 (data not shown).
The VTC1 and/or VMA2 reporter system described above
was then tested with MRI detection. The strains shown
in Figure 1 were cultured in YPD to mid-log phase and trans-
ferred into 0.8 mm glass capillary tubes (Figure 3A) and yeast
cultures and a reference sample (i.e. water) were analyzed by
MRI (Figure 3B). Signals were integrated longitudinally in
each capillary tube and are presented as a bottom view
(Figure 3B, right). The average intensity of the polyP
image was calculated from
31P-MRI data and the area corre-
sponding to each sample was deﬁned spatially using
1H-MRI
data (Figure 3B, left).
Experimental values were measured by northern blot, MRS
and MRI, and values were expressed as a percentage of the
maximum value for each dataset. The results are summarized
in Figure 3C and D. Figure 3D shows the correlation
coefﬁcients between northern blot and MRS or MRI methods.
These results strongly suggest that gene expression can be
quantiﬁed accurately by MRS and MRI using VTC1 or
VMA2 as a reporter gene in yeast cells. To our knowledge,
this is the ﬁrst report describing a fully quantitative reporter
system with MRI detection that can be used to monitor spatial
and temporal variation in gene expression.
In higher eukaryotes, the endogenous level of polyP is much
lower than in yeast (8). In addition, VTC1 orthologs have not
been identiﬁed in mammals whereas mutations of VMA2
orthologs cause genetic disease in humans (22,23). Therefore,
in order to apply a similar reporter system in mammalian cells,
an exogenous MRI reporter gene may be required. Preliminary
results suggest that the Escherichia coli PPK1 gene, which
encodes polyP kinase, is a candidate reporter gene for use in
mammalian cells. PPK1 converts the terminal phosphate of
ATP to polyP (24), and expression of PPK1 from a mamma-
lian promoter induced polyP at a level readily detected by
MRS or MRI in mammalian cells (unpublished results).
Unfortunately, it has not been possible to characterize a
PPK1-based reporter system in yeast, because the endogenous
background of polyP interferes with measurement of induced
PPK1 activity (data not shown). Although organism-speciﬁc
reporter genes may be needed for future studies in mammalian
cells, the system described in this report should be widely
applicable.
In summary, this study presents a novel MR-based method
for quantifying temporal and spatial variation in gene expres-
sion. This method can potentially be used in any tissue of any
organism. Furthermore, this method may have important
applications in the context of high-throughput cell-based
assays, which are used in drug discovery screening and in
many other areas of basic and clinical research.
SUPPLEMENTARY DATA
Supplementary data are available at NAR online.
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